ArticleMedicine2016

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.

Ya-Zhen Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.